Documentation
Français (FR)

Anglais (EN)

Yassamine Lazrek

17

Documents

Publications

	Molecular detection of human Plasmodium species using a multiplex real time PCR Yassamine Lazrek , Célia Florimond , Béatrice Volney , Manon Discours , Emilie Mosnier Scientific Reports, 2023, 13 (1), pp.11388. ⟨10.1038/s41598-023-38621-9⟩ Article dans une revue pasteur-04185534v1
	Kelch13 mutations in Plasmodium falciparum and risk of spreading in Amazon basin countries Luana C. Mathieu , Prabhjot Singh , Wuelton Marcelo Monteiro , Magda Magris , Horace Cox Journal of Antimicrobial Chemotherapy, 2021, 76 (11), pp.2854-2862. ⟨10.1093/jac/dkab264⟩ Article dans une revue hal-03429601v1
	Self-diagnosis and self-treatment of malaria in hard-to-reach and mobile populations of the Amazon: results of Malakit, an international multicentric intervention research project. Maylis Douine , Yann Lambert , Muriel Suzanne Galindo , Louise Mutricy , Alice Sanna The Lancet Regional Health - Americas, 2021, pp.100047. ⟨10.1016/j.lana.2021.100047⟩ Article dans une revue hal-03430898v1
	When local phytotherapies meet biomedicine. Cross-sectional study of knowledge and intercultural practices against malaria in Eastern French Guiana Guillaume Odonne , Lise Musset , C. Cropet , B. Philogene , M. Gaillet Journal of Ethnopharmacology, 2021, 279, pp.114384. ⟨10.1016/j.jep.2021.114384⟩ Article dans une revue hal-03429592v1
	Prevalence of Plasmodium spp. in the Amazonian Border Context (French Guiana–Brazil): Associated Factors and Spatial Distribution Emilie Mosnier , Emmanuel Roux , Claire Cropet , Yassamine Lazrek , Olivier Moriceau American Journal of Tropical Medicine and Hygiene, 2020, 102 (1), pp.130-141. ⟨10.4269/ajtmh.19-0378⟩ Article dans une revue hal-02397337v1
	Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance. Luana Mathieu , Horace Cox , Angela M Early , Sachel Mok , Yassamine Lazrek eLife, 2020, 12, pp.e51015. ⟨10.7554/eLife.51015⟩ Article dans une revue hal-02862736v1
	Paludisme en Guyane : des projets de recherche opérationnelle originaux s'appuyant sur la santé communautaire Emilie Mosnier , Laure Garancher , M. Galindo , Félix Djossou , Olivier Moriceau La Lettre de l'Infectiologue, 2020, Tome XXXV (2), Online ahead of print Article dans une revue inserm-03098603v1
	ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells Christophe Le Clorennec , Yassamine Lazrek , Olivier Dubreuil , Carla Sampaio , Christel Larbouret Cell Communication and Signaling, 2019, 17 (1), pp.106-122. ⟨10.1186/s12964-019-0413-8⟩ Article dans une revue inserm-02280785v1
	Emergence of Plasmodium vivax Resistance to Chloroquine in French Guiana Lise Musset , Christophe Heugas , Richard Naldjinan , Denis Blanchet , Pascal Houzé Antimicrobial Agents and Chemotherapy, 2019, 63 (11), ⟨10.1128/AAC.02116-18⟩ Article dans une revue pasteur-02567258v1
	Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3 Christophe Le Clorennec , Hervé Bazin , Olivier Dubreuil , Christel Larbouret , Charline Ogier Molecular Cancer Therapeutics, 2017, 16 (7), pp.1312-1323. ⟨10.1158/1535-7163.MCT-16-0886⟩ Article dans une revue hal-02434070v1
	Paludisme et orpaillage illégal en Guyane : un enjeu majeur de santé publique Maylis Douine , Lise Musset , Florine Corlin , Stéphane Pelleau , Yassamine Lazrek Bulletin Epidémiologique Hebdomadaire - BEH, 2017, 6, pp.102-114 Article dans une revue inserm-01491193v1
	Predictors of antimalarial self-medication in illegal gold miners in French Guiana: a pathway towards artemisinin resistance. Maylis Douine , Y Lazrek , D. Blanchet , S. Pelleau , R Chanlin Journal of Antimicrobial Chemotherapy, 2017, Epub ahead of print. ⟨10.1093/jac/dkx343⟩ Article dans une revue inserm-01622957v1
	Illegal gold miners in French Guiana: a neglected population with poor health Maylis Douine , Emilie Mosnier , Quentin Le Hingrat , Charlotte Charpentier , Florine Corlin BMC Public Health, 2017, 18 (1), pp.23. ⟨10.1016/S0140-6736(10)62169-1⟩ Article dans une revue inserm-01566314v1
	The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation Christophe Le Clorennec , Yassamine Lazrek , Olivier Dubreuil , Christel Larbouret , Marie-Alix Poul Oncotarget, 2016, 7 (24), pp.37013-37029. ⟨10.18632/oncotarget.9455⟩ Article dans une revue hal-02297403v1
	Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation. Yassamine Lazrek , Olivier Dubreuil , Véronique Garambois , Nadège Gaborit , Christel Larbouret Neoplasia, 2013, 15 (3), pp.335-47. ⟨10.1593/neo.121960⟩ Article dans une revue inserm-00815985v1

	ANTI-HUMAN-HER3 ANTIBODIES AND USES THEREOF Yassamine Lazrek , Thierry Chardès , Christel Larbouret , André Pèlegrin France, Patent n° : WO 2012/156532. 2012 Brevet hal-03706426v1
	The invention relates to antibodies against HER3 and their use in the treatment of cancer. Yassamine Lazrek France, Patent n° : WO 2012/156309. 2012 Brevet hal-03706393v1